E’ville Biz: Marriott Resort Rebranding as Sonesta, Athletic Playground On the lookout for New House, Gritstone Oncology Engaged on “Subsequent Technology” Covid Vaccine

A handful of Emeryville-related business stories have been compiled in this month’s E’ville Biz Digest from across the web.

Last month, the Emeryville Courtyard by Marriott announced it was Reduction of 85 jobs amid the Covid-related decimation of the travel industry. It was later announced that this hotel would be renamed to Sonesta Emeryville Oakland. Sonesta, owned by a real estate investment company Service Properties Trust, has aggressively expanded its portfolio and is expected to do so Add 100 hotels by March.

Space for “playful training” Sporty playground Perhaps they are looking for a new home after the space they rented at 4700 San Pablo Avenue listed on the market. In a newsletter to customers, Athletic Playground described their uncertain future in Emeryville. “It is unknown how long it will be before the building is sold and which potential new owners would like to start the building.” Athletic Playground has called Emeryville “home” for over 12 years.

In addition, Gritsone oncology Makes headlines in life sciences with next-generation Covid vaccine study to address emerging variants. Gristone is also working with Gilead Sciences on an experimental vaccine against the AIDS virus.

Andrew Allen, CEO and Co-Founder of Gritstone (Photo Todd Johnson | SFBT).

HIV vaccine at the center of a potential $ 785 million deal between Gilead, East Bay Biotech

From Ron Leuty

An East Bay cancer drug company that raised its profile last month by working with Covid-19 vaccines announced today that it is working with HIV-fighting powerhouse Gilead Sciences Inc. on an experimental vaccine for AIDS Virus will work.

Emeryville-based Gritstone Oncology Inc. (NASDAQ: GRTS) could receive up to $ 785 million, including an upfront payment of $ 30 million and a $ 30 million equity investment from Gilead (NASDAQ: GILD) of Foster City.

Read more about SF Business Times (Paywall may apply).

ADVERTISING

How an East Bay biotech is applying its cancer know-how to a next-generation Covid vaccine

From Ron Leuty

As potentially dangerous variants of Covid-19 emerge around the world – including a mutant that infiltrated a Kaiser Permanente emergency room in San Jose late last year – a biotech in East Bay outlined plans for a next-generation experimental coronavirus vaccine on Tuesday to fight novel forms of Covid-19 the virus.

Emeryville-based Gritstone Oncology Inc. (NASDAQ: GRTS) announced that it will be working with the National Institute for Allergies and Infectious Diseases on a two-stage Phase I clinical trial of a SARS-CoV-2 vaccine later this quarter will begin. This vaccine would not only break down the “spike” protein that allows the virus to enter cells, but also stimulate part of the immune system to provide a second layer of defense.

Read more about SF Business Times (Paywall may apply).

ADVERTISING

Photo: Google Maps

Eight hotels in the Bay Area will receive the new Sonesta flag

By Alex Barreira

Service Properties Trust, a property-owned real estate investment trust, announced Friday that it was renaming eight of its Bay Area properties under the Sonesta flag to become Sonesta International Hotels Corp. for their management.

The Newton, Massachusetts (NASDAQ: SVC) company is converting the eight hotels in the region along with 80 others to its national portfolio. All hotels were previously labeled and managed by Marriott International.

Read more about SF Business Times (Paywall may apply).

Like this:

To like Loading…